PCovNet: A presymptomatic COVID-19 detection framework using deep learning model using wearables data

While the advanced diagnostic tools and healthcare management protocols have been struggling to contain the COVID-19 pandemic, the spread of the contagious viral pathogen before the symptom onset acted as the Achilles’ heel. Although reverse transcription-polymerase chain reaction (RT-PCR) has been...

Full description

Saved in:
Bibliographic Details
Published inComputers in Biology and Medicine Vol. 147; p. 105682
Main Authors Abir, Farhan Fuad, Alyafei, Khalid, Chowdhury, Muhammad E.H., Khandakar, Amith, Ahmed, Rashid, Hossain, Muhammad Maqsud, Mahmud, Sakib, Rahman, Ashiqur, Abbas, Tareq O., Zughaier, Susu M., Naji, Khalid Kamal
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.08.2022
Elsevier BV
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0010-4825
1879-0534
1879-0534
DOI10.1016/j.compbiomed.2022.105682

Cover

Loading…
More Information
Summary:While the advanced diagnostic tools and healthcare management protocols have been struggling to contain the COVID-19 pandemic, the spread of the contagious viral pathogen before the symptom onset acted as the Achilles’ heel. Although reverse transcription-polymerase chain reaction (RT-PCR) has been widely used for COVID-19 diagnosis, they are hardly administered before any visible symptom, which provokes rapid transmission. This study proposes PCovNet, a Long Short-term Memory Variational Autoencoder (LSTM-VAE)-based anomaly detection framework, to detect COVID-19 infection in the presymptomatic stage from the Resting Heart Rate (RHR) derived from the wearable devices, i.e., smartwatch or fitness tracker. The framework was trained and evaluated in two configurations on a publicly available wearable device dataset consisting of 25 COVID-positive individuals in the span of four months including their COVID-19 infection phase. The first configuration of the framework detected RHR abnormality with average Precision, Recall, and F-beta scores of 0.946, 0.234, and 0.918, respectively. However, the second configuration detected aberrant RHR in 100% of the subjects (25 out of 25) during the infectious period. Moreover, 80% of the subjects (20 out of 25) were detected during the presymptomatic stage. These findings prove the feasibility of using wearable devices with such a deep learning framework as a secondary diagnosis tool to circumvent the presymptomatic COVID-19 detection problem. •A wearable device-based presymptomatic COVID-19 detection framework was proposed.•Resting Heart Rate (RHR) was calculated from heart rate and steps data.•An LSTM Variational Autoencoder-based framework with two separate configurations was proposed for detecting anomalous RHR.•Smartwatch-based RHR monitoring system as a secondary diagnostic tool was validated for continuous health monitoring.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0010-4825
1879-0534
1879-0534
DOI:10.1016/j.compbiomed.2022.105682